Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib in Newly Diagnosed Ph+ CML-CP
NCT00809211Phase 2Completed
- Sponsor
- Cancer Trials Ireland
- Start
- Oct 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of nilotinib in chronic myeloid leukemia (CML), sponsored by Cancer Trials Ireland. Started Oct 2008; status: completed.
02
Drugs
nilotinib
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00809211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00809211.